Travel and Leisure Travel and Leisure

Moderna and Other Vaccine Stocks Climb Amid Concerns About Coronavirus Study in China


Published on 2025-02-21 18:21:17 - Investopedia
  Print publication without navigation

  • He also worked on The Journal's publishing desk; as a writer and editor covering stocks at Barron's; as an editor of features at MarketWatch; and on product development efforts at The Journal. Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday.

The article from Investopedia discusses the surge in stock prices for companies like Moderna, BioNTech, and Novavax following concerns about a new study from China on the ongoing threat of the coronavirus. The study highlighted the potential for the virus to mutate into more dangerous forms, prompting investors to turn towards vaccine manufacturers as a safe bet. Moderna's stock rose by 2.5%, BioNTech by 3.5%, and Novavax by 5.5% in premarket trading. This interest was further fueled by the anticipation of a new vaccine booster campaign in the U.S., aimed at addressing new variants. The article also notes that while the study raised alarms, the actual impact of these mutations on vaccine efficacy remains uncertain, but the market's reaction was clear in its support for vaccine stocks.

Read the Full Investopedia Article at:
[ https://www.investopedia.com/moderna-and-other-vaccine-stocks-climb-amid-concerns-about-coronavirus-study-in-china-11684474 ]